Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Determinants of Community-Related Expenses of US Tax-Exempt Hospitals, 2013.

Begun JW, Trinh HQ.

J Public Health Manag Pract. 2019 Jul/Aug;25(4):316-321. doi: 10.1097/PHH.0000000000000840.

PMID:
31136504
2.

Interleukin-22: friend or foe?

Hasnain SZ, Begun J.

Immunol Cell Biol. 2019 Apr;97(4):355-357. doi: 10.1111/imcb.12249. No abstract available.

PMID:
31012170
3.

Protocol for a pilot randomised controlled trial of mindfulness-based cognitive therapy in youth with inflammatory bowel disease and depression.

Ewais T, Begun J, Kenny M, Chuang KH, Barclay J, Hay K, Kisely S.

BMJ Open. 2019 Apr 20;9(4):e025568. doi: 10.1136/bmjopen-2018-025568.

4.

Clinical decision support improves quality of care in patients with ulcerative colitis.

Jackson B, Begun J, Gray K, Churilov L, Liew D, Knowles S, De Cruz P.

Aliment Pharmacol Ther. 2019 Apr;49(8):1040-1051. doi: 10.1111/apt.15209. Epub 2019 Mar 7.

PMID:
30847962
5.

Trends in lobular carcinoma in situ management: endocrine therapy use in California and New Jersey.

Marmor S, Jerome-D'Emilia B, Begun JW, Hui JYC, Altman AM, Kizy S, Tuttle TM.

Cancer Causes Control. 2019 Feb;30(2):129-136. doi: 10.1007/s10552-019-1126-4. Epub 2019 Jan 17.

PMID:
30656538
6.

A systematic review and meta-analysis of mindfulness based interventions and yoga in inflammatory bowel disease.

Ewais T, Begun J, Kenny M, Rickett K, Hay K, Ajilchi B, Kisely S.

J Psychosom Res. 2019 Jan;116:44-53. doi: 10.1016/j.jpsychores.2018.11.010. Epub 2018 Nov 14. Review.

PMID:
30654993
7.

Letter: vedolizumab drug concentrations in neonates following intrauterine exposure.

Flanagan E, Gibson PR, Begun J, Ghaly S, Garg M, Andrews JM, Rosella O, Rosella G, Bell SJ.

Aliment Pharmacol Ther. 2018 Dec;48(11-12):1328-1330. doi: 10.1111/apt.15027. No abstract available.

PMID:
30488628
8.

A taxonomy of hospitals based on partnerships for population health management.

Noh E, Potthoff S, Begun JW.

Health Care Manage Rev. 2018 Nov 20. doi: 10.1097/HMR.0000000000000230. [Epub ahead of print]

PMID:
30475258
9.

Personalizing inflammatory bowel disease treatment symposium: Foreward.

Begun J.

J Gastroenterol Hepatol. 2018 Sep;33 Suppl 3:3. doi: 10.1111/jgh.14414. No abstract available.

PMID:
30187563
10.

Predictors in inflammatory bowel disease: Looking into the magic ball: Session one summary.

Begun J.

J Gastroenterol Hepatol. 2018 Sep;33 Suppl 3:4. doi: 10.1111/jgh.14415. No abstract available.

PMID:
30187557
11.

Positioning biologics-A case-based discussion: Ustekinumab.

Begun J.

J Gastroenterol Hepatol. 2018 Sep;33 Suppl 3:16-17. doi: 10.1111/jgh.14423. No abstract available.

PMID:
30187551
12.

Selectively targeting the gut in inflammatory bowel disease: Session four summary.

Begun J.

J Gastroenterol Hepatol. 2018 Sep;33 Suppl 3:25. doi: 10.1111/jgh.14430. No abstract available.

PMID:
30187550
13.

Determinants of Community-Related Expenses of US Tax-Exempt Hospitals, 2013.

Begun JW, Trinh HQ.

J Public Health Manag Pract. 2018 Aug 31. doi: 10.1097/PHH.0000000000000840. [Epub ahead of print]

PMID:
30180111
14.

Enterococcus faecalis AHG0090 is a Genetically Tractable Bacterium and Produces a Secreted Peptidic Bioactive that Suppresses Nuclear Factor Kappa B Activation in Human Gut Epithelial Cells.

Ó Cuív P, Giri R, Hoedt EC, McGuckin MA, Begun J, Morrison M.

Front Immunol. 2018 Apr 18;9:790. doi: 10.3389/fimmu.2018.00790. eCollection 2018.

15.

The role of IL-22 in the resolution of sterile and nonsterile inflammation.

Alabbas SY, Begun J, Florin TH, Oancea I.

Clin Transl Immunology. 2018 Apr 18;7(4):e1017. doi: 10.1002/cti2.1017. eCollection 2018. Review.

16.

Embracing uncertainty, managing complexity: applying complexity thinking principles to transformation efforts in healthcare systems.

Khan S, Vandermorris A, Shepherd J, Begun JW, Lanham HJ, Uhl-Bien M, Berta W.

BMC Health Serv Res. 2018 Mar 21;18(1):192. doi: 10.1186/s12913-018-2994-0.

17.

Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application.

Bryant RV, Friedman AB, Wright EK, Taylor KM, Begun J, Maconi G, Maaser C, Novak KL, Kucharzik T, Atkinson NSS, Asthana A, Gibson PR.

Gut. 2018 May;67(5):973-985. doi: 10.1136/gutjnl-2017-315655. Epub 2018 Feb 3. Review.

PMID:
29437914
18.

A Measure of the Potential Impact of Hospital Community Health Activities on Population Health and Equity.

Begun JW, Kahn LM, Cunningham BA, Malcolm JK, Potthoff S.

J Public Health Manag Pract. 2018 Sep/Oct;24(5):417-423. doi: 10.1097/PHH.0000000000000617.

PMID:
29240614
19.

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

Mitrev N, Vande Casteele N, Seow CH, Andrews JM, Connor SJ, Moore GT, Barclay M, Begun J, Bryant R, Chan W, Corte C, Ghaly S, Lemberg DA, Kariyawasam V, Lewindon P, Martin J, Mountifield R, Radford-Smith G, Slobodian P, Sparrow M, Toong C, van Langenberg D, Ward MG, Leong RW; IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1037-1053. doi: 10.1111/apt.14368. Epub 2017 Oct 13. Review.

20.

Colonic thioguanine pro-drug: Investigation of microbiome and novel host metabolism.

Florin T, Movva R, Begun J, Duley J, Oancea I, Cuív PÓ.

Gut Microbes. 2018 Mar 4;9(2):175-178. doi: 10.1080/19490976.2017.1387343. Epub 2017 Oct 17.

21.

Moving Upstream in U.S. Hospital Care Toward Investments in Population Health.

Begun JW, Potthoff S.

J Healthc Manag. 2017 Sep/Oct;62(5):343-353. doi: 10.1097/JHM-D-16-00010.

PMID:
28885536
22.

Knowledge, Beliefs and Attitudes of Somali Men in Olmsted County, Minnesota, U.S., on the Human Papillomavirus Vaccine and Cervical Cancer Screening: January 17, 2015.

Abakporo U, Hussein A, Begun JW, Shippee T.

J Immigr Minor Health. 2018 Oct;20(5):1230-1235. doi: 10.1007/s10903-017-0642-0.

PMID:
28815421
23.

The gut bacterium and pathobiont Bacteroides vulgatus activates NF-κB in a human gut epithelial cell line in a strain and growth phase dependent manner.

Ó Cuív P, de Wouters T, Giri R, Mondot S, Smith WJ, Blottière HM, Begun J, Morrison M.

Anaerobe. 2017 Oct;47:209-217. doi: 10.1016/j.anaerobe.2017.06.002. Epub 2017 Jun 3.

PMID:
28583864
24.

Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles.

Tyagi N, De R, Begun J, Popat A.

Int J Pharm. 2017 Feb 25;518(1-2):220-227. doi: 10.1016/j.ijpharm.2016.12.030. Epub 2016 Dec 14. Review.

PMID:
27988378
25.

Integrated Approach to Reduce Perinatal Adverse Events: Standardized Processes, Interdisciplinary Teamwork Training, and Performance Feedback.

Riley W, Begun JW, Meredith L, Miller KK, Connolly K, Price R, Muri JH, McCullough M, Davis S.

Health Serv Res. 2016 Dec;51 Suppl 3:2431-2452. doi: 10.1111/1475-6773.12592. Epub 2016 Nov 3.

26.

The role of barrier function, autophagy, and cytokines in maintaining intestinal homeostasis.

Elshaer D, Begun J.

Semin Cell Dev Biol. 2017 Jan;61:51-59. doi: 10.1016/j.semcdb.2016.08.018. Epub 2016 Aug 24. Review.

PMID:
27565684
27.

Decreasing Malpractice Claims by Reducing Preventable Perinatal Harm.

Riley W, Meredith LW, Price R, Miller KK, Begun JW, McCullough M, Davis S.

Health Serv Res. 2016 Dec;51 Suppl 3:2453-2471. doi: 10.1111/1475-6773.12551. Epub 2016 Aug 22.

28.

Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism.

Oancea I, Movva R, Das I, Aguirre de Cárcer D, Schreiber V, Yang Y, Purdon A, Harrington B, Proctor M, Wang R, Sheng Y, Lobb M, Lourie R, Ó Cuív P, Duley JA, Begun J, Florin TH.

Gut. 2017 Jan;66(1):59-69. doi: 10.1136/gutjnl-2015-310874. Epub 2016 Jul 13.

29.

High Fat Diets Induce Colonic Epithelial Cell Stress and Inflammation that is Reversed by IL-22.

Gulhane M, Murray L, Lourie R, Tong H, Sheng YH, Wang R, Kang A, Schreiber V, Wong KY, Magor G, Denman S, Begun J, Florin TH, Perkins A, Cuív PÓ, McGuckin MA, Hasnain SZ.

Sci Rep. 2016 Jun 28;6:28990. doi: 10.1038/srep28990.

30.

Genetic Coding Variant in GPR65 Alters Lysosomal pH and Links Lysosomal Dysfunction with Colitis Risk.

Lassen KG, McKenzie CI, Mari M, Murano T, Begun J, Baxt LA, Goel G, Villablanca EJ, Kuo SY, Huang H, Macia L, Bhan AK, Batten M, Daly MJ, Reggiori F, Mackay CR, Xavier RJ.

Immunity. 2016 Jun 21;44(6):1392-405. doi: 10.1016/j.immuni.2016.05.007. Epub 2016 Jun 7.

31.

Inflammatory bowel disease in the clinic: Escalation and de-escalation of therapy: A longitudinal case-based discussion.

Begun J.

J Gastroenterol Hepatol. 2016 Jun;31 Suppl 1:12-3. doi: 10.1111/jgh.13348. No abstract available.

PMID:
26990807
32.

Towards an integrated understanding of the therapeutic utility of exclusive enteral nutrition in the treatment of Crohn's disease.

Cuív PÓ, Begun J, Keely S, Lewindon PJ, Morrison M.

Food Funct. 2016 Apr;7(4):1741-51. doi: 10.1039/c5fo01196e. Review.

PMID:
26948398
33.

The proliferation of elective services in U.S. urban hospitals.

Trinh HQ, Begun JW.

Health Care Manage Rev. 2017 Apr/Jun;42(2):184-190. doi: 10.1097/HMR.0000000000000101.

PMID:
26765481
34.

High-risk centers and the benefits for lower-risk transplants.

Marmor S, Begun JW, Abraham J, Virnig BA.

Am J Manag Care. 2015 Sep 1;21(9):e509-18.

35.

Integrated Genomics of Crohn's Disease Risk Variant Identifies a Role for CLEC12A in Antibacterial Autophagy.

Begun J, Lassen KG, Jijon HB, Baxt LA, Goel G, Heath RJ, Ng A, Tam JM, Kuo SY, Villablanca EJ, Fagbami L, Oosting M, Kumar V, Schenone M, Carr SA, Joosten LA, Vyas JM, Daly MJ, Netea MG, Brown GD, Wijmenga C, Xavier RJ.

Cell Rep. 2015 Jun 30;11(12):1905-18. doi: 10.1016/j.celrep.2015.05.045. Epub 2015 Jun 18.

36.

Enteroliths in a Kock continent ileostomy: case report and review of the literature.

Moattar H, Begun J, Florin T.

Endoscopy. 2015;47 Suppl 1 UCTN:E200-1. doi: 10.1055/s-0034-1391302. Epub 2015 Jun 10. Review. No abstract available.

PMID:
26062147
37.

The impact of center accreditation on hematopoietic cell transplantation (HCT).

Marmor S, Begun JW, Abraham J, Virnig BA.

Bone Marrow Transplant. 2015 Jan;50(1):87-94. doi: 10.1038/bmt.2014.219. Epub 2014 Nov 10.

PMID:
25387091
38.

IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans.

de Luca A, Smeekens SP, Casagrande A, Iannitti R, Conway KL, Gresnigt MS, Begun J, Plantinga TS, Joosten LA, van der Meer JW, Chamilos G, Netea MG, Xavier RJ, Dinarello CA, Romani L, van de Veerdonk FL.

Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3526-31. doi: 10.1073/pnas.1322831111. Epub 2014 Feb 18.

39.

Exploratory analysis of high CT scan utilization in claims data.

Begun JW, Riley WJ, Hodges JS.

J Am Coll Radiol. 2014 Jan;11(1):51-8. doi: 10.1016/j.jacr.2013.04.011. Epub 2013 Nov 5.

PMID:
24200472
40.

Autophagy at the crossroads of metabolism and cellular defense.

Begun J, Xavier RJ.

Curr Opin Gastroenterol. 2013 Nov;29(6):588-96. doi: 10.1097/MOG.0b013e328365d34d. Review.

PMID:
24100719
41.

Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis.

Beaudoin M, Goyette P, Boucher G, Lo KS, Rivas MA, Stevens C, Alikashani A, Ladouceur M, Ellinghaus D, Törkvist L, Goel G, Lagacé C, Annese V, Bitton A, Begun J, Brant SR, Bresso F, Cho JH, Duerr RH, Halfvarson J, McGovern DP, Radford-Smith G, Schreiber S, Schumm PL, Sharma Y, Silverberg MS, Weersma RK; Quebec IBD Genetics Consortium; NIDDK IBD Genetics Consortium; International IBD Genetics Consortium, D'Amato M, Vermeire S, Franke A, Lettre G, Xavier RJ, Daly MJ, Rioux JD.

PLoS Genet. 2013;9(9):e1003723. doi: 10.1371/journal.pgen.1003723. Epub 2013 Sep 12.

42.

The diffusion of Magnet hospital recognition.

Abraham J, Jerome-D'Emilia B, Begun JW.

J Nurs Adm. 2013 Oct;43(10 Suppl):S19-27. doi: 10.1097/01.NNA.0000435147.24090.0e. No abstract available.

PMID:
24022078
43.

Lymph node evaluation for colon cancer in an era of quality guidelines: who improves?

Parsons HM, Begun JW, Kuntz KM, Tuttle TM, McGovern PM, Virnig BA.

J Oncol Pract. 2013 Jul;9(4):e164-71. doi: 10.1200/JOP.2012.000812. Epub 2013 Mar 19.

44.

Public health as a distinct profession: has it arrived?

Evashwick CJ, Begun JW, Finnegan JR Jr.

J Public Health Manag Pract. 2013 Sep-Oct;19(5):412-9. doi: 10.1097/PHH.0b013e31828002d2.

PMID:
23896977
45.

Service duplication within urban hospital clusters.

Trinh HQ, Begun JW, Luke RD.

Health Care Manage Rev. 2014 Jan-Mar;39(1):41-9. doi: 10.1097/HMR.0b013e318282660d.

PMID:
23358131
46.

The LRR and RING domain protein LRSAM1 is an E3 ligase crucial for ubiquitin-dependent autophagy of intracellular Salmonella Typhimurium.

Huett A, Heath RJ, Begun J, Sassi SO, Baxt LA, Vyas JM, Goldberg MB, Xavier RJ.

Cell Host Microbe. 2012 Dec 13;12(6):778-90. doi: 10.1016/j.chom.2012.10.019.

47.

Hospital characteristics associated with maintenance or improvement of guideline-recommended lymph node evaluation for colon cancer.

Parsons HM, Begun JW, McGovern PM, Tuttle TM, Kuntz KM, Virnig BA.

Med Care. 2013 Jan;51(1):60-7. doi: 10.1097/MLR.0b013e318270ba0d.

PMID:
23047124
48.

Quality of care along the cancer continuum: does receiving adequate lymph node evaluation for colon cancer lead to comprehensive postsurgical care?

Parsons HM, Tuttle TM, Kuntz KM, Begun JW, McGovern PM, Virnig BA.

J Am Coll Surg. 2012 Sep;215(3):400-11. doi: 10.1016/j.jamcollsurg.2012.05.014. Epub 2012 Jun 8.

PMID:
22683070
50.

Association between lymph node evaluation for colon cancer and node positivity over the past 20 years.

Parsons HM, Tuttle TM, Kuntz KM, Begun JW, McGovern PM, Virnig BA.

JAMA. 2011 Sep 14;306(10):1089-97. doi: 10.1001/jama.2011.1285.

PMID:
21917579

Supplemental Content

Support Center